ArticleBMC public health2024

Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective.

Jianchun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.